| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |